DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 91 filers reported holding DYNE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $844 | -32.4% | 73,300 | -31.9% | 0.00% | -50.0% |
| Q4 2022 | $1,248 | -99.9% | 107,700 | +2.7% | 0.00% | 0.0% |
| Q3 2022 | $1,332,000 | +112.4% | 104,900 | +15.0% | 0.00% | +100.0% |
| Q2 2022 | $627,000 | +52.2% | 91,200 | +113.6% | 0.00% | – |
| Q1 2022 | $412,000 | -49.4% | 42,700 | -37.7% | 0.00% | -100.0% |
| Q4 2021 | $814,000 | -64.3% | 68,500 | -51.2% | 0.00% | -66.7% |
| Q3 2021 | $2,282,000 | – | 140,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $103,977,000 | 14.71% |
| Vida Ventures Advisors, LLC | 2,960,046 | $62,161,000 | 12.76% |
| Octagon Capital Advisors LP | 481,538 | $10,112,000 | 3.50% |
| Logos Global Management LP | 1,604,392 | $33,692,000 | 2.89% |
| RA Capital Management | 2,805,045 | $58,906,000 | 0.82% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 12,048 | $253,000 | 0.40% |
| HighVista Strategies LLC | 23,760 | $499,000 | 0.32% |
| Vivo Capital, LLC | 315,000 | $6,615,000 | 0.30% |
| Woodline Partners LP | 490,986 | $10,311,000 | 0.27% |
| EcoR1 Capital, LLC | 215,000 | $4,515,000 | 0.24% |